Concern over work-related deaths among Japanese expats
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NHK
10 minutes ago
- NHK
US pushes talks with other partners after Japan deal
With his tariff deadline approaching on August 1, US President Donald Trump is stepping up pressure on other trading partners to build momentum for talks. This comes after he announced a "massive" deal with Japan on Tuesday. Trump posted on social media on Wednesday that the agreement was reached because of "Tariff Power." He said Japan agreed to open its markets "for the first time ever." A photo posted by a White House official shows the negotiations on Tuesday. Trump is holding a board with the words "Japan Invest America." The figure "400 billion dollars" has been crossed out, and new numbers have been written in by hand. Trump later said Japan will invest 550 billion dollars in the US. The White House said Japan has agreed to buy 100 Boeing aircraft and increase defense spending with US firms. It also said Japan will boost purchases of US rice by 75 percent and that it will buy 8 billion dollars of agricultural and other goods. Treasury Secretary Scott Bessent told Bloomberg TV that Tokyo was "ready to deal" and proposed a "very innovative solution." He described the Japanese side as "tough negotiators" but said Trump is "tougher." White House Press Secretary Karoline Leavitt warned other trading partners about dealing with the president. She said: "He will only lower tariff rates if a country agrees to open their market to American made products. If not, they will continue to face tariffs and pay a steep price to do business in the United States of America." South Korea is one of the countries still trying to cut a deal. Negotiators will hold talks with Bessent later this week. Discussions with China are expected to take place early next week in Stockholm.
Nikkei Asia
an hour ago
- Nikkei Asia
Biopharma supply chain plans must navigate contradictory US policies
An employee checks capsules inside a Cadila Pharmaceutical company manufacturing unit in Ahmedabad, India. Not all countries and segments of the biopharmaceutical supply chain will be impacted equally by geopolitical uncertainties. © Reuters Gopal Nadadur is senior vice president for South Asia, Sam Ide is vice president for China, and Alex Melillo is associate vice president for Japan at The Asia Group, a strategic advisory firm headquartered in Washington, D.C. Gopal is based in New Delhi and Sam and Alex are based in Washington, D.C. Asia-based biopharmaceutical supply chains are facing a peak period of geopolitically induced uncertainty. Washington is the key source of this upheaval, with industry strategies simultaneously upended by President Donald Trump's tariffs and onshoring policies, national security-focused regulations and pharmaceutical pricing pressure.
Nikkei Asia
2 hours ago
- Nikkei Asia
Analysis: Xi administration quick to tell civil servants they can drink
Katsuji Nakazawa is a Tokyo-based senior staff and editorial writer at Nikkei. He spent seven years in China as a correspondent and later as China bureau chief. He was the 2014 recipient of the Vaughn-Ueda International Journalist prize. Chinese President and party boss Xi Jinping's administration has been forced to tweak an "alcohol ban" targeting party and government officials after facing a barrage of public criticism.
